VENOUS THROMBOEMBOLISM (VTE)
Clinical trials for VENOUS THROMBOEMBOLISM (VTE) explained in plain language.
Never miss a new study
Get alerted when new VENOUS THROMBOEMBOLISM (VTE) trials appear
Sign up with your email to follow new studies for VENOUS THROMBOEMBOLISM (VTE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Old drug, new hope: colchicine may stop Post-Clot leg damage
Disease control Not yet recruitingThis study tests whether adding colchicine, an anti-inflammatory pill, to standard blood thinners can prevent long-term vein damage after a deep vein thrombosis (DVT) in the leg. About 940 adults with a first acute DVT will receive either colchicine or a placebo for six months an…
Matched conditions: VENOUS THROMBOEMBOLISM (VTE)
Phase: PHASE3 • Sponsor: Azienda Sanitaria Locale ASL 6, Livorno • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
21,000 patients to test if aspirin can replace painful injections after hip fracture
Disease control Not yet recruitingThis study will compare aspirin tablets to daily injections of low molecular weight heparin (LMWH) for preventing dangerous blood clots in people who break their hip. Over 21,000 patients aged 60 and older across 96 UK hospitals will take part. Hospitals will switch between the t…
Matched conditions: VENOUS THROMBOEMBOLISM (VTE)
Phase: NA • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Hip fracture patients at heart risk may benefit from dual blood thinners
Disease control Not yet recruitingThis pilot study tests whether a combination of two blood thinners (rivaroxaban and aspirin) can prevent heart attacks and blood clots in patients who had a hip fracture surgery and also suffered a heart injury. About 100 adults aged 45 and older will be randomly assigned to eith…
Matched conditions: VENOUS THROMBOEMBOLISM (VTE)
Phase: PHASE3 • Sponsor: McMaster University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New scanner could spot dangerous lung clots without radiation
Diagnosis Not yet recruitingThis study will test a new, non-invasive bedside scan (3D-EIT) to see if it can accurately diagnose and monitor pulmonary embolism (blood clots in the lungs) without using radiation. About 115 adults with and without clots will participate. The goal is to provide a safer, easier …
Matched conditions: VENOUS THROMBOEMBOLISM (VTE)
Sponsor: Beijing Tsinghua Chang Gung Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:28 UTC
-
Can a simple blood thinner save teens from deadly clots?
Prevention Not yet recruitingThis study tests whether the blood thinner enoxaparin can prevent dangerous blood clots in teens who are critically ill in the intensive care unit. About 800 high-risk teens will receive either enoxaparin or a placebo. The goal is to see if the drug reduces clots without causing …
Matched conditions: VENOUS THROMBOEMBOLISM (VTE)
Phase: PHASE3 • Sponsor: Johns Hopkins All Children's Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
Quick video may ease pain and fear for new moms needing blood thinners
Symptom relief Not yet recruitingThis study tests whether watching a short, informative video before receiving a blood-thinner injection (LMWH) after childbirth can reduce anxiety and pain. 160 new mothers will be randomly assigned to get either the usual verbal explanation or the explanation plus the video. Res…
Matched conditions: VENOUS THROMBOEMBOLISM (VTE)
Phase: NA • Sponsor: Wolfson Medical Center • Aim: Symptom relief
Last updated Jun 26, 2026 15:48 UTC
-
New tool aims to help blood clot patients choose wisely on blood thinners
Knowledge-focused Not yet recruitingThis study tests a decision aid for people who have had a first blood clot and must decide whether to stop or continue blood thinners after at least 3 months of treatment. The aid provides balanced information on risks and benefits and helps clarify personal values. Researchers w…
Matched conditions: VENOUS THROMBOEMBOLISM (VTE)
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Can virtual care cut hospital errors? duke launches massive study
Knowledge-focused Not yet recruitingThis study will see if using virtual care technologies in hospital units can reduce problems like patient falls, infections, and readmissions, while also improving patient satisfaction. About 10,000 adults admitted to six hospital units will take part, with three units using the …
Matched conditions: VENOUS THROMBOEMBOLISM (VTE)
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC